OR3A4P: A Protein Involved in Fetal Development and Growth (G390756)
OR3A4P: A Protein Involved in Fetal Development and Growth
OR3A4P (OR17-13) is a protein that is expressed in the human placenta and has been shown to play a role in fetal development and growth. The OR3A4P gene has also been implicated in the development and progression of various diseases, including cancer. As a result, OR3A4P has become a focus of interest for researchers and pharmaceutical companies looking for potential drug targets or biomarkers.
The OR3A4P protein is a member of the OR3A family, which is known for its role in the development and maintenance of the placenta. The OR3A family consists of four proteins: OR3A1, OR3A2, OR3A3, and OR3A4P. These proteins are involved in various functions related to placenta development, including cell adhesion, migration, and angiogenesis.
OR3A4P is a 19 kDa protein that is expressed in the human placenta and has been shown to play a role in fetal development and growth. The placenta is a vital organ that plays a critical role in the development and nourishment of the fetus. OR3A4P is involved in the formation and maintenance of the placenta, as well as the regulation of fetal growth and development.
One of the key functions of OR3A4P is its role in the formation of the neural tube, which will eventually become the brain and spinal cord. During fetal development, OR3A4P is involved in the guidance of the neural tube during its formation and the subsequent formation of the brain and spinal cord.
In addition to its role in neural tube formation, OR3A4P is also involved in the regulation of fetal growth and development. The placenta plays a critical role in the regulation of fetal growth and development by controlling the amount of nutrients that are delivered to the fetus. OR3A4P is involved in this regulation by interacting with other proteins involved in fetal nutrition, including the insulin-like growth factor (IGF) 2 receptor.
OR3A4P has also been shown to be involved in the regulation of cellular processes that are important for the development and progression of various diseases, including cancer. For example, OR3A4P has been shown to be involved in the regulation of angiogenesis, the process by which new blood vessels are formed. This is important for the development of many diseases, including cancer, because the growth and development of new blood vessels is a critical factor for their growth and progression.
Despite the potential implications of OR3A4P as a drug target or biomarker, more research is needed to fully understand its role in fetal development and growth. OR3A4P is also a complex protein that is involved in many different cellular processes, which makes it difficult to study. Additionally, the effects of OR3A4P on fetal development and growth may be different from its effects on the development and progression of diseases. Further research is needed to fully understand the role of OR3A4P in these processes.
In conclusion, OR3A4P is a protein that is expressed in the human placenta and has been shown to play a role in fetal development and growth. The OR3A4P gene has also been implicated in the development and progression of various diseases, including cancer. As a result, OR3A4P has become a focus of interest for researchers and pharmaceutical companies looking for potential drug targets or biomarkers. Further research is needed to fully understand the role of OR3A4P in fetal development and growth, as well as its potential as a drug target or biomarker.
Protein Name: Olfactory Receptor Family 3 Subfamily A Member 4 Pseudogene
Functions: Odorant receptor
The "OR3A4P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR3A4P comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
OR4A14P | OR4A15 | OR4A16 | OR4A17P | OR4A21P | OR4A47 | OR4A5 | OR4B1 | OR4C11 | OR4C12 | OR4C13 | OR4C15 | OR4C16 | OR4C1P | OR4C3 | OR4C45 | OR4C46 | OR4C5 | OR4C50P | OR4C6 | OR4D1 | OR4D10 | OR4D11 | OR4D2 | OR4D5 | OR4D6 | OR4D9 | OR4E2 | OR4F13P | OR4F15 | OR4F16 | OR4F17 | OR4F21 | OR4F29 | OR4F3 | OR4F4 | OR4F5 | OR4F6 | OR4G3P | OR4K1 | OR4K13 | OR4K14 | OR4K15 | OR4K17 | OR4K2 | OR4K5 | OR4K6P | OR4K7P | OR4L1 | OR4M1 | OR4M2 | OR4M2-OT1 | OR4N2 | OR4N3P | OR4N4 | OR4N5 | OR4P4 | OR4Q3 | OR4S1 | OR4S2 | OR4T1P | OR4V1P | OR4X1 | OR4X2 | OR51A1P | OR51A2 | OR51A3P | OR51A4 | OR51A6P | OR51A7 | OR51B2 | OR51B4 | OR51B5 | OR51B6 | OR51C1P | OR51D1 | OR51E1 | OR51E2 | OR51F1 | OR51F2 | OR51G1 | OR51G2 | OR51H1 | OR51I1 | OR51I2 | OR51J1 | OR51L1 | OR51M1 | OR51Q1 | OR51S1 | OR51T1 | OR51V1 | OR52A1 | OR52A4P | OR52A5 | OR52B2 | OR52B4 | OR52B6 | OR52D1 | OR52E1
